Abstract
In this investigation, the efficacy of a single intraperitoneal injection of flumequine in the treatment of systemic vibriosis in corkwing wrasse Symphodus melops was examined. In a population of corkwing wrasse that was experiencing daily mortality, the dominant bacterium cultivated from kidney samples of dead fish was tentatively classified as a species of Vibrio resembling V. splendidus. The infected fish were randomly divided into two groups, each of 60 individuals. Group 1 was treated with flumequine (25 mg/kg of fish) administered by a single intraperitoneal injection, whereas the fish from group 2 were injected with saline. The mortality was observed daily for 21 d. The cumulative mortality was significantly (P < 0.005) higher in the control group (58%) compared with the medicated group (11%). Bacterial examination of kidneys from dead and surviving fish of both groups indicated the Vibrio to be quickly and effectively eliminated by the antibacterial agent.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
